1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 23 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancerOlver, I.; Keefe, D.; Myers, M.
2020Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trialHankey, G.J.; Hackett, M.L.; Almeida, O.P.; Flicker, L.; Mead, G.E.; Dennis, M.S.; Etherton-Beer, C.; Ford, A.H.; Billot, L.; Jan, S.; Lung, T.; Murray, V.; Lundström, E.; Anderson, C.S.; Herbert, R.; Carter, G.; Donnan, G.A.; Nguyen, H.T.; Gommans, J.; Yi, Q.; et al.
2016Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACSKhazanie, P.; Hammill, B.G.; Patel, C.B.; Kiernan, M.S.; Cooper, L.B.; Arnold, S.V.; Fendler, T.J.; Spertus, J.A.; Curtis, L.H.; Hernandez, A.F.
2020Long-term follow-up of two randomized trials comparing laparoscopic Nissen 360° with anterior 90° partial fundoplicationHopkins, R.J.; Irvine, T.; Jamieson, G.G.; Devitt, P.G.; Watson, D.I.
2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerSmit, E.; Burgers, S.; Biesma, B.; Smit, H.; Eppinga, P.; Dingemans, A.; Joerger, M.; Schellens, J.; Vincent, A.; van Zandwijk, N.; Groen, H.
2015Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisDe Cruz, P.; Kamm, M.A.; Hamilton, A.L.; Ritchie, K.J.; Krejany, E.O.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.C.; Andrews, J.M.; Bampton, P.A.; Jakobovits, S.; Florin, T.H.; Gibson, P.R.; Debinski, H.; Gearry, R.B.; Macrae, F.A.; Leong, R.W.; Kronborg, I.; Radford-Smith, G.; et al.
2013Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyRoss, D.; Branford, S.; Seymour, J.; Schwarer, A.; Arthur, C.; Yeung, D.; Dang, P.; Goyne, J.; Slader, C.; Filshie, R.; Mills, A.; Vaz de Melo, J.; White, D.; Grigg, A.; Hughes, T.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2010Apixaban for reduction in stroke and other ThromboemboLic events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationaleLopes, R.; Alexander, J.; Al-Khatib, S.; Ansell, J.; Diaz, R.; Easton, J.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Hylek, E.; McMurray, J.; Verheugt, F.; Wallentin, L.
2007A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitisKahrilas, P.; Dent, J.; Lauritsen, K.; Malfertheiner, P.; Denison, H.; Franzen, S.; Hasselgren, G.

Discover